ReviewClinical journal of oncology nursing2025
Noninvasive Continuous Temperature Monitoring in Oncology and Future Directions.
Review in Clinical journal of oncology nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diurnal variations of fever in children: results from an app-based observational study.BMC pediatrics · 2026Observational
- Achieving High-Temperature Measurement Using Thermionic Emission from a W-LaMaterials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis review describes the current state of noninvasive continuous temperature monitoring (CTM) in oncology and future directions for CTM.
objectivesMEDLINE®, Google Scholar™, and ClinicalTrials.gov databases were searched for articles published from April 1, 2019, to April 30, 2024, to evaluate the use of wearable CTM devices. The validity of the evidence and the regulatory status of U.S. Food and Drug Administration 510(k)-cleared devices were assessed to determine the benefits and limitations of using CTM for detecting febrile neutropenia.
methodsIn total, 178 unique studies were screened, 64 were selected for additional review, and 15 met inclusion criteria and used one of four brands of 510(k)-cleared medical-grade devices.
findingsThe benefits of CTM identified in this review include improved patient outcomes, increased cost savings, ease and reliability of use, increased patient mobility, and the ability to wirelessly and remotely monitor patients. The feasibility, usability, and satisfaction in patients and caretakers were established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.